Enoxaparin Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 81952-130
  • Package NDC 81952-130-06
  • Application number ANDA205660
  • SPL ID 5d7516f0-ac10-55df-e063-6294a90a55fb
  • SPL set ID 31e7c4d0-ba45-4b20-8e25-2d12892372e5
  • UNII 8NZ41MIK1O
  • RxCUI 854228
  • RxCUI 854235
  • RxCUI 854238
  • RxCUI 854241
  • RxCUI 854245
  • RxCUI 854248
  • RxCUI 854252

What the source publishes

Labeler
Hepalink USA Inc.
Active ingredients
Enoxaparin Sodium
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:81952-130_5d7516f0-ac10-55df-e063-6294a90a55fb
{
  "name": "Enoxaparin Sodium",
  "splId": "5d7516f0-ac10-55df-e063-6294a90a55fb",
  "labels": [
    {
      "setId": "31e7c4d0-ba45-4b20-8e25-2d12892372e5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31e7c4d0-ba45-4b20-8e25-2d12892372e5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31e7c4d0-ba45-4b20-8e25-2d12892372e5"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Hepalink USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 SYRINGE in 1 CARTON (81952-130-06)  / 1 mL in 1 SYRINGE (81952-130-01)",
      "package_ndc": "81952-130-06",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230427"
    }
  ],
  "productId": "81952-130_5d7516f0-ac10-55df-e063-6294a90a55fb",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "81952-130",
  "deaSchedule": null,
  "genericName": "Enoxaparin Sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ENOXAPARIN SODIUM",
      "strength": "100 mg/mL"
    }
  ],
  "applicationNumber": "ANDA205660",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230315",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0381952130015",
      "0381952124243",
      "0381952128289",
      "0381952126162",
      "0381952124144",
      "0381952128180",
      "0381952132286",
      "0381952123130",
      "0381952135010",
      "0381952130060",
      "0381952135065",
      "0381952123239",
      "0381952132187"
    ],
    "unii": [
      "8NZ41MIK1O"
    ],
    "rxcui": [
      "854228",
      "854235",
      "854238",
      "854241",
      "854245",
      "854248",
      "854252"
    ],
    "spl_set_id": [
      "31e7c4d0-ba45-4b20-8e25-2d12892372e5"
    ],
    "manufacturer_name": [
      "Hepalink USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:81952-130_5d7516f0-ac10-55df-e063-6294a90a55fb"